SAN FRANCISCO, Aug. 1, 2018 — King & Spalding advised Claret Medical in its acquisition by Boston Scientific Corp. (NYSE: BSX) in a transaction consisting of $220 million up front and up to an additional $50 million in milestone payments.
Claret Medical is a privately-held company headquartered in Santa Rosa, Calif. Its portfolio includes the Sentinel Cerebral Embolic Protection System, a medical device that is intended to address the risk of stroke in patients undergoing transcatheter aortic valve replacement (TAVR). The company was founded in 2009. Massachusetts-based Boston Scientific is a global developer, manufacturer and marketer of medical devices.
The King & Spalding team advising Claret was led by San Francisco-based partner Geoff Leonard (San Francisco) and included counsel Jen DePalma (Silicon Valley), senior associate Robert Benson (Atlanta), and associate Katy Alexander (San Francisco/Silicon Valley)
Additional support was provided by partners Elaine Tseng (San Francisco), Preeya Pinto (Washington, D.C.) and Chris Markus (Washington, D.C.) on FDA & regulatory issues; partner Becky Kaufman (Atlanta) on intellectual property issues; partners Ken Raskin (New York) and counsel Mark Kelly (Atlanta) on compensation and benefits questions; counsel Brian Meiners (Washington, D.C.) on antitrust issues; partner Cheryl Sabnis (San Francisco) on labor and employment issues; and partner Wayne Pressgrove (Atlanta), senior associate Robert Beard (Atlanta) and associate Greg Lucas (Atlanta) on tax questions.
About King & Spalding
Celebrating more than 130 years of service, King & Spalding is an international law firm that represents a broad array of clients, including half of the Fortune Global 100, with 1,000 lawyers in 20 offices in the United States, Europe, the Middle East and Asia. The firm has handled matters in over 160 countries on six continents and is consistently recognized for the results it obtains, uncompromising commitment to quality, and dedication to understanding the business and culture of its clients. More information is available at www.kslaw.com.